A Strife

3.2k total citations
59 papers, 2.7k citations indexed

About

A Strife is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, A Strife has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Hematology, 24 papers in Genetics and 18 papers in Molecular Biology. Recurrent topics in A Strife's work include Chronic Myeloid Leukemia Treatments (25 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (18 papers). A Strife is often cited by papers focused on Chronic Myeloid Leukemia Treatments (25 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Acute Myeloid Leukemia Research (18 papers). A Strife collaborates with scholars based in United States, Slovakia and Switzerland. A Strife's co-authors include Bayard D. Clarkson, David Wisniewski, C Lambek, B Clarkson, Nick Carpino, Jerrold Fried, Ryûji Kobayashi, Bruce Stillman, Daniel R. Marshak and Étienne de Harven and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

A Strife

59 papers receiving 2.6k citations

Peers

Countries citing papers authored by A Strife

Since Specialization

Citations

This map shows the geographic impact of A Strife's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Strife with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Strife more than expected).

Fields of papers citing papers by A Strife

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Strife. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Strife. The network helps show where A Strife may publish in the future.

Co-authorship network of co-authors of A Strife

This figure shows the co-authorship network connecting the top 25 collaborators of A Strife. A scholar is included among the top collaborators of A Strife based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Strife. A Strife is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies 2003 ·Leukemia ·B Clarkson, A Strife, David Wisniewski, C Lambek, (unknown)	83
2	Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells. 2003 ·PubMed ·A Strife, David Wisniewski, (unknown), C Lambek, Zbigniew Darżynkiewicz, Richard T. Silver, Bayard D. Clarkson	12
3	Phosphatidylinositol 3-Kinase and Src Family Kinases Are Required for Phosphorylation and Membrane Recruitment of Dok-1 in c-Kit Signaling 2002 ·Journal of Biological Chemistry ·Xiquan Liang, David Wisniewski, A Strife, (unknown), Bayard D. Clarkson, Marilyn D. Resh	45
4	Characterization of two novel sublines established from a human megakaryoblastic leukemia cell line transfected with p210BCR-ABL 2000 ·Leukemia Research ·Ellin Berman, Suresh C. Jhanwar, Mary L. McBride, A Strife, David Wisniewski, C Lambek, Bayard Clarkson	8
5	The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the Dok1 phosphoprotein in Bcr-Abl transformed cells 2000 ·Cellular Signalling ·(unknown), David Wisniewski, A Strife, Bayard Clarkson, Marilyn D. Resh	23
6	A Novel SH2-Containing Phosphatidylinositol 3,4,5-Trisphosphate 5-Phosphatase (SHIP2) Is Constitutively Tyrosine Phosphorylated and Associated With src Homologous and Collagen Gene (SHC) in Chronic Myelogenous Leukemia Progenitor Cells 1999 ·Blood ·David Wisniewski, A Strife, (unknown), Hediye Erdjument‐Bromage, Scott Geromanos, W. Michael Kavanaugh, Paul Tempst, Bayard D. Clarkson	117
7	Molecular Cloning and Characterization of p56 Defines a New Family of RasGAP-binding Proteins 1998 ·Journal of Biological Chemistry ·Antonio Di Cristofano, Nick Carpino, (unknown), (unknown), Ryûji Kobayashi, A Strife, David Wisniewski, Bayard D. Clarkson, Pier Paolo Pandolfi, Marilyn D. Resh	114
8	New understanding of the pathogenesis of CML: a prototype of early neoplasia 1997 ·Leukemia ·(unknown), A Strife, David Wisniewski, C Lambek, Nick Carpino	59
9	p62 : A Constitutively Tyrosine-Phosphorylated, GAP-Associated Protein in Chronic Myelogenous Leukemia Progenitor Cells 1997 ·Cell ·Nick Carpino, David Wisniewski, A Strife, Daniel R. Marshak, Ryûji Kobayashi, Bruce Stillman, Bayard D. Clarkson	334
10	c-kit ligand stimulates tyrosine phosphorylation of the c-Cbl protein in human hematopoietic cells. 1996 ·PubMed ·David Wisniewski, A Strife, B Clarkson	32
11	Differences in the composition and in the efficiency of red cell production of normal and CML erythroid progenitor populations are highlighted by response to human c-kit ligand 1993 ·Leukemia Research ·A Strife, (unknown), C Lambek, David Wisniewski, Silvia Bruno, Zbigniew Darżynkiewicz, Bayard D. Clarkson	10
12	Integration of Molecular and Biological Abnormalities in Quest for Selective Treatment of Chronic Myelogenous Leukemia (CML) 1993 ·Leukemia & lymphoma ·B Clarkson, A Strife, Alexendar R. Perez, C Lambek, David Wisniewski	6
13	Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment. 1993 ·PubMed ·Bayard Clarkson, A Strife	56
14	Constitutive expression of p53 protein in enriched normal human marrow blast cell populations [see comments] 1992 ·Blood ·(unknown), David Wisniewski, A Strife, Alexendar R. Perez, C Lambek, Stefania Bruno, Zbigniew Darżynkiewicz, B Clarkson	29
15	Co-detection of chimeric bcr/abl (target) and β-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction 1991 ·Leukemia Research ·David Wisniewski, A Strife, Bayard D. Clarkson	7
16	Monoclonal antibody YB5.B8 identifies the human c-kit protein product 1991 ·Blood ·(unknown), K Nocka, (unknown), (unknown), A Strife, LK Ashman, Peter Besmer	139
17	Biology of chronic myelogenous leukemia: is discordant maturation the primary defect? 1988 ·PubMed ·A Strife, Bayard D. Clarkson	87
18	Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients. 1986 ·Proceedings of the National Academy of Sciences ·James B. Konopka, Susan Spierre Clark, J McLaughlin, (unknown), Yoshiro Kato, A Strife, Bayard Clarkson, Owen N. Witte	30
19	Incidence of involvement of the B and T lymphocyte lineages in chronic myelogenous leukemia 1985 ·Blood ·(unknown), Yoshiro Kato, A Strife, (unknown), Jerrold Fried, Alexendar R. Perez, S.C. Jhanwar, (unknown), RS Chaganti, B Clarkson	74
20	Evaluation of a Feulgen- type reaction in suspension using flow microfluorimetry and a cell separation technique. 1975 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Xenophon Yataganas, (unknown), Frank Traganos, A Strife, B Clarkson	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact